Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
IPILIMUMAB 200 MG/40ML IV SOLN (NDC 00003232822) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved November 9, 2026 , from http://ppman.hank.ai/transparency/procedure/00003232822/by-state?code_type=NDC
“IPILIMUMAB 200 MG/40ML IV SOLN (NDC 00003232822) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/00003232822/by-state?code_type=NDC. Accessed
November 9, 2026 .
“IPILIMUMAB 200 MG/40ML IV SOLN (NDC 00003232822) by State,” HANK Price Transparency ,
accessed November 9, 2026 ,
http://ppman.hank.ai/transparency/procedure/00003232822/by-state?code_type=NDC.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
NDC · across United States
00003232822 — Ipilimumab 200 Mg/40ml IV Soln
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$44,609
National median
$3 – $56,775
IQR (p25 – p75)
12
hospitals filing
5
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 00003232822 (NDC), with interquartile range
State Median p25 p75
MD $69,811 $69,811 $69,811
CA $56,775 $40,959 $60,831
MI $56,058 $45,191 $70,007
OH $42,378 $177 $59,167
FL $2 $1 $2